New therapies for systemic lupus erythematosus — past imperfect, future tense
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New therapies for systemic lupus erythematosus — past imperfect, future tense
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 15, Issue 7, Pages 403-412
Publisher
Springer Science and Business Media LLC
Online
2019-06-05
DOI
10.1038/s41584-019-0235-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
- (2018) Fengchun Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
- (2018) Luca Iaccarino et al. JOURNAL OF AUTOIMMUNITY
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosus
- (2018) Pedro L Carreira et al. RHEUMATOLOGY
- Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis
- (2018) Qiong Yin et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
- (2018) Ronald F van Vollenhoven et al. LANCET
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
- (2017) Eoghan M McCarthy et al. RHEUMATOLOGY
- Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
- (2017) R. Aguiar et al. ARTHRITIS CARE & RESEARCH
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
- (2016) Julie Ducreux et al. RHEUMATOLOGY
- Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
- (2016) Yasuko Furumoto et al. Arthritis & Rheumatology
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Why and how should we measure disease activity and damage in lupus?
- (2014) Joy Feld et al. PRESSE MEDICALE
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- B-cell-targeted therapies in systemic lupus erythematosus
- (2013) Vera Sau-Fong Chan et al. Cellular & Molecular Immunology
- Atherosclerosis in Systemic Lupus Erythematosus
- (2013) George Stojan et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Brutonˈs tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system
- (2013) Gabriela López-Herrera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Taking a closer look at biologic therapy for SLE
- (2013) David A. Isenberg et al. Nature Reviews Rheumatology
- Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
- (2012) Robert Zimmer et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid
- (2012) Bernard R. Lauwerys et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- The genetics of type I interferon in systemic lupus erythematosus
- (2012) Paola G Bronson et al. CURRENT OPINION IN IMMUNOLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus
- (2012) Jack Hutcheson et al. ARTHRITIS RESEARCH & THERAPY
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Assessment of a lupus nephritis cohort over a 30-year period
- (2011) S. C. Croca et al. RHEUMATOLOGY
- FcγRIIB, FcγRIIIB, and systemic lupus erythematosus
- (2010) Heather A. Niederer et al. Annals of the New York Academy of Sciences
- IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
- (2010) Rui-Xue Leng et al. ARCHIVES OF MEDICAL RESEARCH
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- The role of B cells in lupus pathogenesis
- (2009) Emil Nashi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality
- (2009) F Goldblatt et al. LUPUS
- The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by γδ T Cells
- (2009) Nicolas Page et al. PLoS One
- Interferon Alpha-Induced Lupus
- (2008) Timothy B. Niewold JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now